PMGC Holdings Inc

ELAB

5.536USD

-0.209-3.64%

Market hours （ET）Quotes delayed by 15 min

PMGC Holdings Inc's Score

Industry at a Glance

Industry Ranking

64 / 78

Overall Ranking

488 / 4616

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

--

Current Rating

--

Target Price

--

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

PMGC Holdings Inc Highlights

StrengthsRisks

PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 0.00.

Overvalued

The company’s latest PE is 0.03, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 11.49K shares, decreasing 68.59% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.78K shares of this stock.

The company's current financial score is 6.72, which is lower than the Healthcare Providers & Services industry's average of 7.24. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

6.72

Change

0



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.29

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.67

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.63

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.03

Key Metrics

Free cash flow

No Data

The company’s current valuation score is 8.17, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 0.03, which is 72.24% below the recent high of 0.05 and 79345.20% above the recent low of -22.27.

Score

Industry at a Glance

Previous score

8.17

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 64/78

No Data

There is no earnings forecast score for this company; the Healthcare Providers & Services industry's average is 7.56.

Score

Industry at a Glance

Previous score

0.00

Change

0

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The company’s current price momentum score is 2.48, which is lower than the Healthcare Providers & Services industry's average of 7.02. Sideways: Currently, the stock price is trading between the resistance level at 9.58 and the support level at 3.45, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.50

Change

-0.02

Support & Resistance

No Data

Institutional Confidence

Currency: USD Updated: 2025-11-04

Score

Industry at a Glance

Previous score

3.00

Change

0

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Streeterville Capital LLC

90.45K

--

L1 Capital Global Opportunities Master Fund Ltd.

47.31K

+20380.09%

Citadel Advisors LLC

5.09K

--

Geode Capital Management, L.L.C.

2.08K

--

The Vanguard Group, Inc.

Star Investors

1.78K

--

Sabby Management, LLC

1.52K

-86.20%

UBS Financial Services, Inc.

802.00

+83.94%

BWL Investments Ltd

390.00

+0.26%

Tower Research Capital LLC

215.00

-37.13%

MOA Life Plus Co,Ltd.

194.00

--



1

2



The company’s current risk assessment score is 1.30, which is lower than the Healthcare Providers & Services industry's average of 5.44. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

PMGC Holdings Inc

ELAB

3.83 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Natera Inc

NTRA

8.63 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Ensign Group Inc

ENSG

8.33 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Encompass Health Corp

EHC

8.32 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Pediatrix Medical Group Inc

MD

8.30 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Option Care Health Inc

OPCH

8.12 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment